These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28002974)

  • 1. Proteomics for early prenatal screening of pregnancy complications: a 2017 perspective.
    Kolialexi A; Mavreli D; Papantoniou N
    Expert Rev Proteomics; 2017 Feb; 14(2):113-115. PubMed ID: 28002974
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of proteomics for diagnosis of fetal aneuploidies and pregnancy complications.
    Kolialexi A; Anagnostopoulos AK; Mavrou A; Tsangaris GT
    J Proteomics; 2009 Jul; 72(5):731-9. PubMed ID: 19332162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of differential proteins of placenta tissues in patients with pre-eclampsia by iTRAQ proteomics techniques.
    Qi WH; Zheng MY; Li C; Xu L; Xu JE
    Minerva Med; 2017 Oct; 108(5):389-395. PubMed ID: 28728340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preeclamptic toxemia: a disease ripe for proteomic discovery.
    Baker PN; Myers JE
    Expert Rev Proteomics; 2009 Apr; 6(2):107-10. PubMed ID: 19385936
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting Preterm Birth Using Proteomics.
    Marić I; Stevenson DK; Aghaeepour N; Gaudillière B; Wong RJ; Angst MS
    Clin Perinatol; 2024 Jun; 51(2):391-409. PubMed ID: 38705648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redefining preeclampsia using placenta-derived biomarkers.
    Staff AC; Benton SJ; von Dadelszen P; Roberts JM; Taylor RN; Powers RW; Charnock-Jones DS; Redman CW
    Hypertension; 2013 May; 61(5):932-42. PubMed ID: 23460278
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia.
    Myers JE; Tuytten R; Thomas G; Laroy W; Kas K; Vanpoucke G; Roberts CT; Kenny LC; Simpson NA; Baker PN; North RA
    Hypertension; 2013 Jun; 61(6):1281-8. PubMed ID: 23547239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic-driven biomarker discovery in gestational diabetes mellitus: a review.
    Singh A; Subramani E; Datta Ray C; Rapole S; Chaudhury K
    J Proteomics; 2015 Sep; 127(Pt A):44-9. PubMed ID: 26216595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
    Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
    Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia.
    Blankley RT; Gaskell SJ; Whetton AD; Dive C; Baker PN; Myers JE
    BJOG; 2009 Oct; 116(11):1473-80. PubMed ID: 19663911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do we improve treatments for patients with amyloidosis using proteomics?
    Lavatelli F; Merlini G
    Expert Rev Proteomics; 2017 Jul; 14(7):561-563. PubMed ID: 28524784
    [No Abstract]   [Full Text] [Related]  

  • 12. Applying proteomics to detect early signs of chronic kidney disease: where has the magic gone?
    Klein JB
    Expert Rev Proteomics; 2017 May; 14(5):387-390. PubMed ID: 28363249
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular aspects of preeclampsia.
    Mohaupt M
    Mol Aspects Med; 2007 Apr; 28(2):169-91. PubMed ID: 17412411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery.
    Mary S; Patil GV; Kulkarni AV; Kulkarni MJ; Joshi SR; Mehendale SS; Giri AP
    Proteomics Clin Appl; 2012 Jan; 6(1-2):79-90. PubMed ID: 22447695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing Potential Candidates of Preclinical Preeclampsia.
    Founds S; Zeng X; Lykins D; Roberts JM
    Int J Mol Sci; 2015 Nov; 16(11):27208-27. PubMed ID: 26580600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry.
    Park JS; Oh KJ; Norwitz ER; Han JS; Choi HJ; Seong HS; Kang YD; Park CW; Kim BJ; Jun JK; Syn HC
    Reprod Sci; 2008 May; 15(5):457-68. PubMed ID: 18579854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for proteomics in kidney stone disease.
    Vinaiphat A; Thongboonkerd V
    Expert Rev Proteomics; 2017 Mar; 14(3):185-187. PubMed ID: 28092479
    [No Abstract]   [Full Text] [Related]  

  • 18. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preeclampsia: molecular mechanisms, predisposition, and treatment.
    Vitoratos N; Vrachnis N; Iavazzo C; Kyrgiou M
    J Pregnancy; 2012; 2012():145487. PubMed ID: 22690336
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical proteomics in obstetrics and neonatology.
    Klein J; Buffin-Meyer B; Mullen W; Carty DM; Delles C; Vlahou A; Mischak H; Decramer S; Bascands JL; Schanstra JP
    Expert Rev Proteomics; 2014 Feb; 11(1):75-89. PubMed ID: 24404900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.